T cell populations in children with autism spectrum disorder and co-morbid gastrointestinal symptoms

Abdallah, 2013, Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders, World J. Biol. Psychiatr., 14, 528, 10.3109/15622975.2011.639803 Abdallah, 2012, Neonatal levels of cytokines and risk of autism spectrum disorders: an exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank, J. Neuroimmunol., 252, 75, 10.1016/j.jneuroim.2012.07.013 Abdallah, 2013, Neonatal levels of neurotrophic factors and risk of autism spectrum disorders, Acta Psychiatr. Scand., 128, 61, 10.1111/acps.12020 Ahmad, 2017, Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism, Mol. Neurobiol., 54, 4390, 10.1007/s12035-016-9977-0 Akintunde, 2015, Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma, J. Neuroimmunol., 286, 33, 10.1016/j.jneuroim.2015.07.003 Al-Ayadhi, 2012, Elevated serum levels of interleukin-17A in children with autism, J. Neuroinflammation, 9, 158, 10.1186/1742-2094-9-158 Al-Ayadhi, 2013, Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children, J. Neuroinflammation, 10, 72, 10.1186/1742-2094-10-72 Annunziato, 2007, Phenotypic and functional features of human Th17 cells, J. Exp. Med., 204, 1849, 10.1084/jem.20070663 Ashwood, 2018, Differential T cell levels of tumor necrosis factor receptor-II in children with autism, Front. Psychiatr., 9 Ashwood, 2004, Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10, J. Clin. Immunol., 24, 664, 10.1007/s10875-004-6241-6 Ashwood, 2011, In search of cellular immunophenotypes in the blood of children with autism, PloS One, 6, 10.1371/journal.pone.0019299 Ashwood, 2008, Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes, J. Neuroimmunol., 204, 149, 10.1016/j.jneuroim.2008.07.006 Ashwood, 2011, Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome, Brain Behav. Immun., 25, 40, 10.1016/j.bbi.2010.08.003 Ashwood, 2011, Altered T cell responses in children with autism, Brain Behav. Immun., 25, 840, 10.1016/j.bbi.2010.09.002 Ashwood, 2011, Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders, J. Neuroimmunol., 232, 196, 10.1016/j.jneuroim.2010.10.025 Association, 2013 Basdeo, 2017, Ex-Th17 (nonclassical Th1) cells are functionally distinct from classical Th1 and Th17 cells and are not constrained by regulatory T cells, J. Immunol., 198, 2249, 10.4049/jimmunol.1600737 Basheer, 2018, Immune aberrations in children with Autism Spectrum Disorder: a case-control study from a tertiary care neuropsychiatric hospital in India, Psychoneuroendocrinology, 94, 162, 10.1016/j.psyneuen.2018.05.002 Bauman, 2010, Medical comorbidities in autism: challenges to diagnosis and treatment, Neurotherapeutics, 7, 320, 10.1016/j.nurt.2010.06.001 Braunschweig, 2008, Autism: maternally derived antibodies specific for fetal brain proteins, Neurotoxicology, 29, 226 Brynskikh, 2008, Adaptive immunity affects learning behavior in mice, Brain Behav. Immun., 22, 861, 10.1016/j.bbi.2007.12.008 Buie, 2010, Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report, Pediatrics, 125, S1, 10.1542/peds.2009-1878C Cabanlit, 2007, Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder, Ann. N. Y. Acad. Sci., 1107, 92, 10.1196/annals.1381.010 Careaga, 2017, Immune endophenotypes in children with autism spectrum disorder, Biol. Psychiatr., 10.1016/j.biopsych.2015.08.036 Chaidez, 2014, Gastrointestinal problems in children with autism, developmental delays or typical development, J. Autism Dev. Disord., 44, 1117, 10.1007/s10803-013-1973-x Chen, 2013, Comorbidity of allergic and autoimmune diseases in patients with autism spectrum disorder: a nationwide population-based study, Res. Autism Spectr. Disord., 7, 205, 10.1016/j.rasd.2012.08.008 Coury, 2012, Gastrointestinal conditions in children with autism spectrum disorder: developing a research agenda, Pediatrics, 130, S160, 10.1542/peds.2012-0900N Critchfield, 2011, The potential role of probiotics in the management of childhood autism spectrum disorders, Gastroenterol. Res. Pract. 2011, 161358 Croen, 2005, Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study, Arch. Pediatr. Adolesc. Med., 159, 151, 10.1001/archpedi.159.2.151 Croonenberghs, 2002, Activation of the inflammatory response system in autism, Neuropsychobiology, 45, 1, 10.1159/000048665 Croonenberghs, 2002, Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism, Psychol. Med., 32, 1457, 10.1017/S0033291702006037 Derecki, 2010, Regulation of learning and memory by meningeal immunity: a key role for IL-4, J. Exp. Med., 207, 1067, 10.1084/jem.20091419 Enstrom, 2009, Increased IgG4 levels in children with autism disorder, Brain Behav. Immun., 23, 389, 10.1016/j.bbi.2008.12.005 Enstrom, 2008, Detection of IL-17 and IL-23 in plasma samples of children with autism, Am. J. Biochem. Biotechnol., 2, 7 Enstrom, 2009, Altered gene expression and function of peripheral blood natural killer cells in children with autism, Brain Behav. Immun., 23, 124, 10.1016/j.bbi.2008.08.001 Enstrom, 2010, Differential monocyte responses to TLR ligands in children with autism spectrum disorders, Brain Behav. Immun., 24, 64, 10.1016/j.bbi.2009.08.001 Feng, 2014, Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus, Cell, 158, 749, 10.1016/j.cell.2014.07.031 Floess, 2007, Epigenetic control of the foxp3 locus in regulatory T cells, PLoS Biol., 5, e38, 10.1371/journal.pbio.0050038 Fontenot, 2003, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nat. Immunol., 4, 330, 10.1038/ni904 Frye, 2016, Blocking and binding folate receptor alpha autoantibodies identify novel autism spectrum disorder subgroups, Front. Neurosci., 10, 80, 10.3389/fnins.2016.00080 Galvez, 2014, Role of Th17 cells in the pathogenesis of human IBD, ISRN Inflamm., 2014, 928461, 10.1155/2014/928461 Gartlan, 2017, Th17 plasticity and transition toward a pathogenic cytokine signature are regulated by cyclosporine after allogeneic SCT, Blood Adv., 1, 341, 10.1182/bloodadvances.2016002980 Gidaya, 2016, In utero exposure to β-2-adrenergic receptor agonist drugs and risk for autism spectrum disorders, Pediatrics: peds, 137, 10.1542/peds.2015-1316 Goines, 2011, Autoantibodies to cerebellum in children with autism associate with behavior, Brain Behav. Immun., 25, 514, 10.1016/j.bbi.2010.11.017 Goines, 2011, Increased midgestational IFN-gamma, IL-4 and IL-5 in women bearing a child with autism: a case-control study, Mol. Autism., 2, 13, 10.1186/2040-2392-2-13 Gupta, 1998, Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism, J. Neuroimmunol., 85, 106, 10.1016/S0165-5728(98)00021-6 Harrington, 2006, Expanding the effector CD4 T-cell repertoire: the Th17 lineage, Curr. Opin. Immunol., 18, 349, 10.1016/j.coi.2006.03.017 Hertz-Picciotto, 2006, The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism, Environ. Health Perspect., 114, 1119, 10.1289/ehp.8483 Heuer, 2008, Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms, Autism Res., 1, 275, 10.1002/aur.42 Hirota, 2011, Fate mapping of IL-17-producing T cells in inflammatory responses, Nat. Immunol., 12, 255, 10.1038/ni.1993 Hoffmann, 2009, Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation, Eur. J. Immunol., 39, 1088, 10.1002/eji.200838904 Horvath, 2002, Autism and gastrointestinal symptoms, Curr. Gastroenterol. Rep., 4, 251, 10.1007/s11894-002-0071-6 Instanes, 2015, Attention-deficit/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases, Biol. Psychiatr., 81, 452, 10.1016/j.biopsych.2015.11.024 Jyonouchi, 2014, Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: an inflammatory subtype?, J. Neuroinflammation, 11, 187, 10.1186/s12974-014-0187-2 Jyonouchi, 2005, Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention, Neuropsychobiology, 51, 77, 10.1159/000084164 Jyonouchi, 2012, Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study, J. Neuroinflammation, 9, 4, 10.1186/1742-2094-9-4 Jyonouchi, 2001, Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression, J. Neuroimmunol., 120, 170, 10.1016/S0165-5728(01)00421-0 Kanner, 1943, Autistic disturbances of affective contact, Nerv. Child, 2, 33 Kipnis, 2004, T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions, Proc. Natl. Acad. Sci. U. S. A., 101, 8180, 10.1073/pnas.0402268101 Kleinewietfeld, 2013, The plasticity of human Treg and Th17 cells and its role in autoimmunity, Semin. Immunol., 25, 305, 10.1016/j.smim.2013.10.009 Kohane, 2012, The Co-morbidity burden of children and young adults with autism spectrum disorders, PloS One, 7, 10.1371/journal.pone.0033224 Kolls, 2010, The role of Th17 cytokines in primary mucosal immunity, Cytokine Growth Factor Rev., 21, 443, 10.1016/j.cytogfr.2010.11.002 Kotey, 2014, Co-occurrence of autism and asthma in a nationally-representative sample of children in the United States, J. Autism Dev. Disord., 44, 3083, 10.1007/s10803-014-2174-y Krakowiak, 2015, Neonatal cytokine profiles associated with autism spectrum disorder, Biol. Psychiatr. Krakowiak, 2017, Neonatal cytokine profiles associated with autism spectrum disorder, Biol. Psychiatr., 81, 442, 10.1016/j.biopsych.2015.08.007 Langridge, 2013, Maternal conditions and perinatal characteristics associated with autism spectrum disorder and intellectual disability, PloS One, 8, 10.1371/journal.pone.0050963 Lee, 2009, Late developmental plasticity in the T helper 17 lineage, Immunity, 30, 92, 10.1016/j.immuni.2008.11.005 Leonard, 2006, Maternal health in pregnancy and intellectual disability in the offspring: a population-based study, Ann. Epidemiol., 16, 448, 10.1016/j.annepidem.2005.05.002 Levisohn, 2007, The autism-epilepsy connection, Epilepsia, 48, 33, 10.1111/j.1528-1167.2007.01399.x Lin, 2013, Advances in distinguishing natural from induced Foxp3(+) regulatory T cells, Int. J. Clin. Exp. Pathol., 6, 116 Lopez-Cacho, 2016, Characterization of immune cell phenotypes in adults with autism spectrum disorders, J. Invest. Med., 64, 1179, 10.1136/jim-2016-000070 Lyall, 2014, Maternal immune-mediated conditions, autism spectrum disorders, and developmental delay, J. Autism Dev. Disord., 44, 1546 Maenner, 2012, Brief report: association between behavioral features and gastrointestinal problems among children with autism spectrum disorder, J. Autism Dev. Disord., 42, 1520, 10.1007/s10803-011-1379-6 Malik, 2011, Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects, Immunobiology, 216, 80, 10.1016/j.imbio.2010.03.001 Mannion, 2016, An investigation of comorbid psychological disorders, sleep problems, gastrointestinal symptoms and epilepsy in children and adolescents with autism spectrum disorder: a two year follow-up, Res. Autism Spectr. Disord., 22, 20, 10.1016/j.rasd.2015.11.002 Manzardo, 2012, Plasma cytokine levels in children with autistic disorder and unrelated siblings, Int. J. Dev. Neurosci., 30, 121, 10.1016/j.ijdevneu.2011.12.003 May-Benson, 2009, Incidence of pre-, peri-, and post-natal birth and developmental problems of children with sensory processing disorder and children with autism spectrum disorder, Front. Integr. Neurosci., 3, 31, 10.3389/neuro.07.031.2009 Moaaz, 2019, Th17/Treg cells imbalance and their related cytokines (IL-17, IL-10 and TGF-beta) in children with autism spectrum disorder, J. Neuroimmunol., 337, 577071, 10.1016/j.jneuroim.2019.577071 Molloy, 2003, Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders, Autism, 7, 165, 10.1177/1362361303007002004 Molloy, 2006, Familial autoimmune thyroid disease as a risk factor for regression in children with Autism Spectrum Disorder: a CPEA Study, J. Autism Dev. Disord., 36, 317, 10.1007/s10803-005-0071-0 Mostafa, 2010, Frequency of CD4+CD25high regulatory T cells in the peripheral blood of Egyptian children with autism, J. Child Neurol., 25, 328, 10.1177/0883073809339393 Mostafa, 2008, Allergic manifestations in autistic children: relation to disease severity, J. Pediatr. Neurol., 6, 115 Nakayama, 2017, Th2 cells in health and disease, Annu. Rev. Immunol., 35, 53, 10.1146/annurev-immunol-051116-052350 Niehus, 2006, Early medical history of children with autism spectrum disorders, J. Dev. Behav. Pediatr., 27, S120, 10.1097/00004703-200604002-00010 Okada, 2007, Decreased serum levels of transforming growth factor-beta1 in patients with autism, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 31, 187, 10.1016/j.pnpbp.2006.08.020 Omenetti, 2015, The Treg/Th17 Axis: a dynamic balance regulated by the gut microbiome, Front. Immunol., 6 Onishi, 2010, Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease, Immunology, 129, 311, 10.1111/j.1365-2567.2009.03240.x Onore, 2009, Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders, J. Neuroimmunol., 216, 126, 10.1016/j.jneuroim.2009.09.005 Ousley, 2014, Autism spectrum disorder: defining dimensions and subgroups, Curr. Dev. Disord. Rep., 1, 20, 10.1007/s40474-013-0003-1 Paul, 2010, How are TH2-type immune responses initiated and amplified?, Nat. Rev. Immunol., 10, 225, 10.1038/nri2735 Peck, 2010, Precarious balance: Th17 cells in host defense, Infect. Immun., 78, 32, 10.1128/IAI.00929-09 Ricci, 2013, Altered cytokine and BDNF levels in autism spectrum disorder, Neurotox. Res., 24, 491, 10.1007/s12640-013-9393-4 Rose, 2014, Potential cytokine biomarkers in autism spectrum disorders, Biomarkers Med., 8, 1171, 10.2217/bmm.14.39 Rose, 2019, Rapid communication: plasma interleukin-35 in children with autism, Brain Sci., 9, 152, 10.3390/brainsci9070152 Rose, 2018, Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms, Brain Behav. Immun., 70, 354, 10.1016/j.bbi.2018.03.025 Sacco, 2012, Cluster Analysis of autistic patients based on principal pathogenetic components, Autism Res., 5, 137, 10.1002/aur.1226 Singer, 2006, Antibrain antibodies in children with autism and their unaffected siblings, J. Neuroimmunol., 178, 149, 10.1016/j.jneuroim.2006.05.025 Singh, 1996, Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism, J. Neuroimmunol., 66, 143, 10.1016/0165-5728(96)00014-8 Singh, 1997, Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation, Biol. Psychiatr., 41, 753, 10.1016/S0006-3223(96)00522-7 Singh, 1993, Antibodies to myelin basic protein in children with autistic behavior, Brain Behav. Immun., 7, 97, 10.1006/brbi.1993.1010 Stubbs, 1977, Depressed lymphocyte responsiveness in autistic children, J. Autism Child. Schizophr., 7, 49, 10.1007/BF01531114 Suzuki, 2011, Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders, PloS One, 6, 10.1371/journal.pone.0020470 Sweeten, 2003, High blood monocyte counts and neopterin levels in children with autistic disorder, Am. J. Psychiatr., 160, 1691, 10.1176/appi.ajp.160.9.1691 Theoharides, 2016, Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders, Transl. Psychiatry, 6, e844, 10.1038/tp.2016.77 Toker, 2013, Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus, J. Immunol., 190, 3180, 10.4049/jimmunol.1203473 Ueno, 2018, Th17 plasticity and its relevance to inflammatory bowel disease, J. Autoimmun., 87, 38, 10.1016/j.jaut.2017.12.004 Valicenti-McDermott, 2006, Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease, J. Dev. Behav. Pediatr., 27, S128, 10.1097/00004703-200604002-00011 Walker, 2006, Questionnaire on pediatric gastrointestinal symptoms, Rome III version (QPGS-RIII) Wang, 2013, Mbd2 promotes foxp3 demethylation and T-regulatory-cell function, Mol. Cell Biol., 33, 4106, 10.1128/MCB.00144-13 Wei, 2009, Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells, Immunity, 30, 155, 10.1016/j.immuni.2008.12.009 Wills, 2009, Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders, Brain Behav. Immun., 23, 64, 10.1016/j.bbi.2008.07.007 Xue, 2008, Autism spectrum disorders: concurrent clinical disorders, J. Child Neurol., 23, 6, 10.1177/0883073807307102 Zerbo, 2015, Immune mediated conditions in autism spectrum disorders, Brain Behav. Immun., 46, 232, 10.1016/j.bbi.2015.02.001 Zerbo, 2015, Immune mediated conditions in autism spectrum disorders, Brain Behav. Immun., 46, 232, 10.1016/j.bbi.2015.02.001 Zerbo, 2014, Neonatal cytokines and chemokines and risk of autism spectrum disorder: the early markers for autism (EMA) study: a case-control study, J. Neuroinflammation, 11, 113, 10.1186/1742-2094-11-113 Zhou, 2009, Plasticity of CD4+ T cell lineage differentiation, Immunity, 30, 646, 10.1016/j.immuni.2009.05.001